Skip to main content

Advertisement

Log in

[18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methods

  • Original Article
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

The aim of this study was to evaluate fluorine-18 fluorodeoxyglucose ([18F]FDG) imaging of head and neck tumours using a second- or third-generation hybrid PET device. Results were compared with the findings of spiral computed tomography (CT) and magnetic resonance imaging (MRI), and, as regards lymph node metastasis, the ultrasound findings. A total of 116 patients with head and neck tumours (83 males and 33 females aged 27–88 years) were examined using a hybrid PET scanner after injection of 185–350 MBq of [18F]FDG (Picker Prism 2000 XP-PCD, Marconi Axis γ-PET2 AZ). Hybrid PET examinations were performed in list mode using an axial filter. Reconstruction of data was performed iteratively. Ninety-six patients underwent CT using a multislice technique (Siemens Somatom Plus 4, Marconi MX 8000), 18 patients underwent MRI and 100 patients were examined by ultrasound. All findings were verified by histology, which was considered the gold standard, or, in the event of negative histology, by follow-up. Correct diagnosis of the primary or recurrent lesion was made in 73 of 85 patients using the hybrid PET scanner, in 50 of 76 patients on CT and in 7 of 10 patients on MRI. Hybrid PET successfully visualised metastatic disease in cervical lymph nodes in 28 of 34 patients, while 23 of 31 were correctly diagnosed with CT, 3 of 4 with MRI and 30 of 33 with ultrasound. False positive results regarding lymph node metastasis were seen in three patients with hybrid PET, in 14 patients with CT and in 13 patients with ultrasound. MRI yielded no false positive results concerning lymph node metastasis. In one patient, unrecognised metastatic lesions were seen on hybrid PET elsewhere in the body (lung: n=1; bone: n=1). Additional malignant lesions at sites other than the head and neck tumour were found in three patients (one patient with lung cancer, one patient with pelvic metastasis due to a carcinoma of the prostate and one patient with pulmonary metastasis due to breast cancer). It is concluded that [18F]FDG PET with hybrid PET scanners is superior to CT and MRI in the diagnosis of primary or recurrent lesions as well as in the assessment of lymph node involvement, whereas it is inferior to ultrasound in the detection of cervical lymph node metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1a, b.
Fig. 2a, b.
Fig. 3a, b.
Fig. 4a, b.

Similar content being viewed by others

References

  1. Laubenbacher C, Saumweber D, Wagner-Manslau C, Kau R J, Herz M, Avril N, Ziegler S, Kruschke C, Arnold W, Schwaiger M. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995; 36:1747–1757.

    CAS  PubMed  Google Scholar 

  2. Nowak B, Di Martino E, Jänicke S, Cremerius U, Adam G, Zimny M, Reinartz P, Büll U. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI. Nuklearmedizin 1999; 38:312–318.

    CAS  PubMed  Google Scholar 

  3. Shah JP. Cervical lymph node metastases—diagnostic, therapeutic and prognostic implications. Oncology 1990; 4:61–69.

    CAS  Google Scholar 

  4. Ali S, Tiwar RM, Snow GB. False positive and false-negative neck nodes. Head Neck Surg 1985; 8:78–82.

    CAS  PubMed  Google Scholar 

  5. Hillsamer PJ, Schuller DE, McGhee RB, Chakeres D, Young DC. Improving diagnostic accuracy of cervical metastases with computed tomography and magnetic resonance imaging. Arch Otolaryngol Head Neck Surg 1990; 116:1297–1301.

    CAS  PubMed  Google Scholar 

  6. van den Brekel MWM, Stel HV, Castelijns JA, Nauta JJ, van der Waal I, Valk J, Meyer CJ, Snow GB. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 1990; 177:379–384.

    PubMed  Google Scholar 

  7. Dillon WP, Harnsberger HR. The impact of radiologic imaging on staging of cancer of the head and neck. Semin Oncol 1991; 18:64–79.

    CAS  Google Scholar 

  8. Quetz JU, Rohr S, Hoffmann P, Wustrow J, Mertens J. B-image sonography in lymph node staging of the head and neck area. A comparison with palpation, computerized and magnetic resonance tomography. HNO 1991; 39:61–63.

    CAS  PubMed  Google Scholar 

  9. van den Brekel MWM, Catelijns JA, Croll GA, Stel HV, Valk J, van der Waal I, Golding RP, Meyer CJ, Snow GB. Magnetic resonance imaging versus palpation of cervical lymph node metastases. Arch Otolaryngol Head Neck Surg 1991; 117:666–673.

    Google Scholar 

  10. Heppt W, Haels J, Lenarz T, Mende U, Gademann G. Detection and assessment of cervical lymph node metastases in head-neck tumors. A comparison of methods. Laryngorhinootologie 1989; 68:327–332.

    CAS  PubMed  Google Scholar 

  11. Minn H, Joensuu H, Ahonen A, Klemi P. Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo. Cancer 1988; 61:1776–1781.

    CAS  PubMed  Google Scholar 

  12. Minn H, Clavo A C, Grenman R, Wahl R L. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose andl-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med 1995; 36:252–258.

    CAS  PubMed  Google Scholar 

  13. Haberkorn U, Strauss L G, Reisser C, Haag D, Dimitrakopoulou A, Ziegler S, Oberdorfer F, Rudat V, van Kaick G. Glucose uptake, perfusion and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. J Nucl Med 1991; 32:1548–1555.

    CAS  PubMed  Google Scholar 

  14. Jarritt PH, Acton PD. PET imaging using gamma camera systems: a review. Nucl Med Commun 1996; 17:758–766.

    CAS  PubMed  Google Scholar 

  15. Zimny M, Kaiser H-J, Cremerius U, Sabri O, Schreckenberger M, Reinartz P, Büll U. F-18-FDG-Positronen-Emissions-Tomographie bei onkologischen Patienten: Doppelkopf-Koinzidenz-Gammakamera versus Vollring-PET. Nuklearmedizin 1999; 38:108–114.

    CAS  PubMed  Google Scholar 

  16. Pichler R, Maschek W, Hatzl-Griesenhofer M, Huber H, Wimmer G, Wahl G, Fridrik M. Klinische Wertigkeit der Befunde von FDG-PET mittels Koinzidenz-Gammakamera beim Staging and Restaging maligner Lymphome: ein Vergleich zu konventioneller Diagnostik. Nuklearmedizin 2000; 39:166–173.

    CAS  PubMed  Google Scholar 

  17. Harnsberger H, Mancuso A, Muraki A, Parkin J. The upper aerodigestive tract and neck: CT evaluation of recurrent tumors. Radiology 1983; 149:403–409.

    Google Scholar 

  18. Bronstein AD, Nyberg DA, Schwartz AN, Schumann WP, Griffin BR. Soft tissue changes after head and neck radiation: CT findings. Am J Neurol Rad 1989; 10:171–175.

    CAS  Google Scholar 

  19. Jabour BA, Choi Y, Hoh CK, Rege SD, Soong JC, Lufkin RB, Hanafee WN, Maddahi J, Chaiken L, Bailet J. Extracranial head and neck: PET imaging with 2-[F-18] fluoro-2-deoxy-d-glucose and MR imaging correlation. Radiology 1993; 186:27–35.

    CAS  PubMed  Google Scholar 

  20. Anzai Y, Carroll WR, Quint DJ, Bradford CR, Minoshima S, Wolf GT, Wahl RL. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2[F-18]-fluoro-d-glucose PET and MR imaging diagnosis. Radiology 1996; 200:135–141.

    CAS  PubMed  Google Scholar 

  21. Bailet JW, Abemayor E, Jabour BA, Hawkins RA, Hoh C, Ward PH. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumours and assessment of cervical adenopathy. Laryngoscope 1992; 102:281–288.

    CAS  PubMed  Google Scholar 

  22. Braams JW, Pruim J, Kole AC, Nikkels PG, Vaalburg W, Vermey A, Roodenburg JL. Detection of unknown primary head and neck tumours by positron emissions tomography. Int J Oral Maxillofac Surg 1997; 26:112–115.

    CAS  PubMed  Google Scholar 

  23. Engel H, Steinert H, Buck A, Berthold T, Boni AH, von Schulthess GK. Whole-body PET: physiological and artifactual fluordeoxyglucose accumulations. J Nucl Med 1996; 37:441–446.

    CAS  PubMed  Google Scholar 

  24. Lapela M, Grenman R, Kurki T, Joensuu H, Leskinen S, Lindholm P, Haaparanta M, Ruotsalainen U, Minn H. Head and neck cancer: detection of recurrence with PET and 2-[F18]fluoro-2-deoxy-d-glucose. Radiology 1995; 197:205–211.

    CAS  PubMed  Google Scholar 

  25. Stokkel MPM, Terhaard CHJ, Hordijk GJ, van Rijk PP. The detection of local recurrent head and neck cancer with fluorine-18 fluorodeoxyglucose dual-head positron emission tomography. Eur J Nucl Med 1999; 26:767–773.

    Google Scholar 

  26. Braams JW, Pruim J, Freling NJM, Nikkels PG, Roodenburg JL, Boering G, Vaalburg W, Vermey A. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 1995; 36:211–216.

    CAS  PubMed  Google Scholar 

  27. Mc Guirt WF, Williams DW, Keyes JW, Greven KM, Watson NE, Geisinger KR, Cappellari JO. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography. Laryngoscope 1995; 105:373–375.

    Google Scholar 

  28. Abdel-Nabi H, Spaulding MB, Behar P, Nguyen A, Simpson G, Gona J. Value of PET-FDG imaging in the pre-operative work-up of patients with head and neck carcinomas. J Nucl Med 1996; 37:136P.

    Google Scholar 

  29. Stokkel MPM, ten Broek FW, van Rijk PP. Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: a pilot study. Eur J Nucl Med 1999; 26:499–503.

    Article  CAS  PubMed  Google Scholar 

  30. Stokkel MPM, van Isselt JW, Hoekstra A, van Rijk PP. Lesions of 4 mm and 5 mm detected with18F-FDG using a dual head coincidence camera [abstract]. Eur J Nucl Med 1998; 25:1032.

    Google Scholar 

  31. Jungehülsing M, Scheidhauer K, Damm M, Pietrzyk U, Eckel H, Schicha H, Stennert E. 2[F]-fluoro-2-deoxy-d-glucose positron emission tomography is a sensitive tool for the detection of occult primary cancer (carcinoma of unknown primary syndrome) with head and neck lymph node manifestation. Otolaryngol Head Neck Surg 2000; 123:294–301.

    PubMed  Google Scholar 

  32. Pfluger T, Vollmar C, Wismuller A, Dresel S, Berger F, Suntheim P, Leinsinger G, Hahn K. Quantitative comparison of automatic and interactive methods for MRI-SPECT image registration of the brain based on 3-dimensional calculation of error. J Nucl Med 2000; 41:1823–1829.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S. Dresel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dresel, S., Grammerstorff, J., Schwenzer, K. et al. [18F]FDG imaging of head and neck tumours: comparison of hybrid PET and morphological methods. Eur J Nucl Med Mol Imaging 30, 995–1003 (2003). https://doi.org/10.1007/s00259-003-1181-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-003-1181-6

Keywords

Navigation